Clinical Trial Update: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease [Phase 1]

View source ↗

Summary

This clinical trial update reports the first-in-human Phase 1 study of SRP-1005 for Huntington's disease and indicates the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• SRP-1005

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Huntington's Disease | Phase 1 | Status: NOT_YET_RECRUITING